Short Interest in Senestech, Inc. (NASDAQ:SNES) Drops By 49.7%

Senestech, Inc. (NASDAQ:SNESGet Free Report) was the recipient of a significant decline in short interest during the month of July. As of July 15th, there was short interest totaling 27,608 shares, a decline of 49.7% from the June 30th total of 54,875 shares. Currently, 0.5% of the shares of the company are short sold. Based on an average trading volume of 64,738 shares, the days-to-cover ratio is currently 0.4 days.

Senestech Stock Performance

NASDAQ:SNES traded down $0.01 on Tuesday, reaching $1.32. 3,761 shares of the company’s stock were exchanged, compared to its average volume of 61,401. The firm has a market cap of $7.00 million, a price-to-earnings ratio of -0.70 and a beta of 0.28. The company has a debt-to-equity ratio of 0.02, a current ratio of 8.91 and a quick ratio of 7.79. The stock has a fifty day simple moving average of $1.57 and a 200-day simple moving average of $1.76. Senestech has a 52 week low of $1.31 and a 52 week high of $6.24.

Senestech (NASDAQ:SNESGet Free Report) last announced its quarterly earnings results on Tuesday, May 12th. The company reported ($0.31) EPS for the quarter, beating analysts’ consensus estimates of ($0.33) by $0.02. The company had revenue of $0.49 million for the quarter, compared to analysts’ expectations of $0.63 million. Senestech had a negative net margin of 304.22% and a negative return on equity of 67.60%. As a group, sell-side analysts predict that Senestech will post -1.57 earnings per share for the current year.

Insider Buying and Selling at Senestech

In related news, major shareholder Glenbrook Capital Management purchased 35,000 shares of the firm’s stock in a transaction dated Tuesday, June 30th. The stock was bought at an average price of $1.51 per share, for a total transaction of $52,850.00. Following the purchase, the insider directly owned 1,022,824 shares in the company, valued at approximately $1,544,464.24. This trade represents a 3.54% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Over the last ninety days, insiders have purchased 108,773 shares of company stock worth $173,352. 2.20% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Senestech

Institutional investors have recently made changes to their positions in the stock. Diversify Wealth Management LLC purchased a new position in shares of Senestech in the first quarter valued at $31,000. Jane Street Group LLC purchased a new stake in Senestech during the 4th quarter worth about $32,000. Diversify Advisory Services LLC bought a new position in Senestech in the 4th quarter worth about $34,000. XTX Topco Ltd purchased a new position in Senestech during the 4th quarter valued at about $54,000. Finally, Geode Capital Management LLC purchased a new position in Senestech during the 2nd quarter valued at about $59,000. Hedge funds and other institutional investors own 5.19% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings raised Senestech from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday, July 10th. One research analyst has rated the stock with a Strong Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Hold”.

Check Out Our Latest Report on Senestech

Senestech Company Profile

(Get Free Report)

SenesTech, Inc (NASDAQ: SNES) is a biotechnology company specializing in non-lethal pest management solutions. The company’s core focus is the development and commercialization of fertility-based control methods for commensal rodents, providing an alternative to traditional rodenticides. By targeting the reproductive cycle of rats, SenesTech aims to reduce rodent populations over time without the use of toxic chemicals, offering a more sustainable approach for pest management professionals.

The company’s flagship product, ContraPest®, is an EPA-registered liquid bait that disrupts rodent reproduction.

Recommended Stories

Receive News & Ratings for Senestech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senestech and related companies with MarketBeat.com's FREE daily email newsletter.